APA (7th ed.) Citation

CA, F., M, S., J, D., B, S., O, G., TA, D., . . . W, H. (2023). Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study. Open forum infectious diseases, 10(8), ofad417. https://doi.org/10.1093/ofid/ofad417

Chicago Style (17th ed.) Citation

CA, Fierro, et al. "Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia Coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study." Open Forum Infectious Diseases 10, no. 8 (2023): ofad417. https://doi.org/10.1093/ofid/ofad417.

MLA (9th ed.) Citation

CA, Fierro, et al. "Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia Coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study." Open Forum Infectious Diseases, vol. 10, no. 8, 2023, p. ofad417, https://doi.org/10.1093/ofid/ofad417.